International Drug Prevention Declarations

harmreductionInternational Task Force on Strategic Drug Policy


Representing drug prevention, treatment, and policy organizations from around the world, the International Task Force on Strategic Drug Policy met in Brussels, Belgium on Feb 27-28 to discuss effective drug policy strategies and compose this statement on so-called “harm reduction.”

We support the United Nations position that the goal of national and global drug policies and strategies must be to prevent or stop drug use.  We agree with the United Nations that drug demand reduction is a fundamental pillar to sound drug policy. We support abstinence from drug use as a reasonable and achievable goal for public health policy.

We support a policy of no use of illegal drugs or destructive use of legal drugs.

We support rational drug policies which recognize that the temporary use of measures to reduce harm with the goal of ultimate abstinence are fundamentally different from so-called “harm reduction” drug policies which accept the inevitability of drug use.

The phrase “harm reduction” and its obvious meaning has been hijacked and cynically employed by those whose goal is to legalize drugs. They use the obvious, universal desire to reduce harm to promote the legalization of drugs. Drug legalizers use the phrase to gain the sympathy of well-meaning people and government officials.

We oppose so-called “harm reduction” strategies as endpoints that promote the false notion that there are safe or responsible ways to use drugs.  That is, strategies in which the primary goal is to enable drug users to maintain addictive, destructive, and compulsive behavior by misleading users about some drug risks while ignoring others.  These strategies give the message that society has given up on the addict, condones their drug use, and condemns them to a life of drug dependence. So-called “harm reduction” as a drug strategy undermines drug prevention efforts and messages by taking advantage of drug addiction and deadly diseases like HIV to advance the political agenda of drug legalization lobbyists and billionaire advocates.

We support the International Narcotics Control Board (INCB) position on so-called “harm reduction” that does not support stand alone needle exchange programs and so called ”safe” injecting rooms because such policies encourage drug use and violate UN Conventions. Article 4 of the 1961 Convention, which:

  • …obliges State parties to ensure that the production, manufacture import, export, distribution of, trade in, use and possession of, drugs is limited exclusively to medical and scientific purposes. Therefore, from a legal point of view such facilities violate international drug control conventions.

We oppose usurping multi-national treaties and agreements and replacing the goal of preventing and reducing drug use with a strategy by whatever name (e.g. so-called “harm reduction”) that seeks to normalize various forms of drug use.

We support comprehensive prevention, treatment, and enforcement strategies to prevent and eliminate illegal drug use, and thereby their undeniable harm. We support harm prevention and harm elimination through expanding treatment, outreach, and social services for drug users, addicts, and those with infectious diseases. We support research into effective outreach and treatment techniques for addict populations.

It is insufficient, illogical, and inhumane to proclaim that drug dependence should be maintained in the name of so-called “harm reduction.” History, science, and reason tell us that drug use can be prevented, and drug dependence can be overcome and its attendant consequences reduced, if not eliminated.

Signatories to the International Task Force on Strategic Drug Policy

Sonita Abrahams –  JAMAICA Dr. Hans Koeppel – SWITZERLAND
Dr. Ernst Aeschbach – SWITZERLAND MaLou Lindholm – SWEDEN
Franklin Alcaraz – BOLIVIA Christy McCampbell – USA
Omar Aleman – CUBA Paquita Moncayo – ECUADOR
Al Arsenault – CANADA Dr. Ian Oliver – SCOTLAND
Laura Baldivieso – BOLIVIA Dr. Bruce Payette – USA
Dan Bent – USA Robert Peterson – USA
Salomao Bernstein – BRAZIL Harold Rahm – BRAZIL
Florencia Di Masi Alconada – ARGENTINA David Raynes — ENGLAND
Don Feder – USA Dr. Eliseo Regadas Gonzalez – URUGUAY
Dr. Guillermo Fernandez – ARGENTINA Jose Luis Rojas – CHILE
Jack Gilligan – USA Kevin Sabet – USA
Stella Santana – BRAZIL Ricardo Sanchez Huesca – MEXICO
Dr. Mina Seinfeld de Carakushansky – BRAZIL Betty Sembler – USA
Calvina Fay – USA Ann Stoker – ENGLAND
Maria Margarita Sanchez – COLOMBIA Peter Stoker – ENGLAND
Dr. David Gross – USA Dr. Ivan Van Damme – BELGIUM
Stephanie Haynes – USA Alejandro Vassilaqui – PERU
Brian Heywood – ENGLAND Dr. Eric Voth – USA
Dr. Ed Jacobs – USA Dr. Juan Yaria – ARGENTINA
Ben Jenkins – CANADA

Category: Drug News